Tricida Total Non Current Liabilities 2011-2025 | TCDA

Annual Total Non Current Liabilities Tricida

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	13.2 M	68.2 M	38.5 M	217 K	67.1 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
68.2 M	217 K	37.4 M

Quarterly Total Non Current Liabilities Tricida

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	440 K	483 K	-	323 K	-	323 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
483 K	323 K	392 K

Total Non Current Liabilities of other stocks in the Drug manufacturers industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Alimera Sciences ALIM	46.5 M	-	-	$ 142 M	USA
Aerie Pharmaceuticals AERI	274 M	-	-	$ 754 M	USA
AcelRx Pharmaceuticals ACRX	104 M	-	7.5 %	$ 6.35 M	USA
Cronos Group CRON	10.7 M	$ 2.67	0.19 %	$ 1.39 B	Canada
Adamis Pharmaceuticals Corporation ADMP	7.44 M	-	0.86 %	$ 117 M	USA
Catalent CTLT	3.83 B	-	-	$ 11.5 B	USA
Agile Therapeutics AGRX	16.4 M	-	10.11 %	$ 58.2 M	USA
DURECT Corporation DRRX	26.4 M	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	36.6 M	-	-39.89 %	$ 27.7 M	USA
Aurora Cannabis ACB	681 M	$ 4.34	-3.45 %	$ 86.3 M	Canada
Endo International plc ENDP	8.8 B	-	-	$ 28.9 M	Irlanda
Zomedica Corp. ZOM	275	-	-0.21 %	$ 98 M	USA
Evoke Pharma EVOK	6.61 M	-	-	$ 36.6 M	USA
Calliditas Therapeutics AB (publ) CALT	316 M	-	-0.1 %	$ 2.03 B	Schweden
HEXO Corp. HEXO	38.2 M	-	2.45 %	$ 38.1 M	Canada
Zynerba Pharmaceuticals ZYNE	110 K	-	-	$ 55.5 M	USA
Emergent BioSolutions EBS	1.02 B	$ 12.24	-1.49 %	$ 627 M	USA
Athenex ATNX	157 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	134 M	$ 21.55	-0.21 %	$ 2.05 B	France
Evolus EOLS	102 M	$ 6.67	-3.41 %	$ 414 M	USA
Harrow Health HROW	19.8 M	$ 50.49	0.79 %	$ 1.65 B	USA
China Pharma Holdings CPHI	1.71 M	$ 1.23	-6.82 %	$ 21.5 M	China
OrganiGram Holdings OGI	107 M	$ 1.72	-3.91 %	$ 402 M	Canada
Neoleukin Therapeutics NLTX	11.4 M	-	-	$ 193 M	Canada
Organogenesis Holdings ORGO	105 M	$ 5.18	-1.9 %	$ 682 M	USA
Bausch Health Companies BHC	26.5 B	$ 7.12	-1.11 %	$ 2.6 B	Canada
Lannett Company LCI	677 M	-	1.15 %	$ 7.11 M	USA
Sonoma Pharmaceuticals SNOA	991 K	$ 3.7	2.15 %	$ 4.59 M	USA
Cumberland Pharmaceuticals CPIX	23.9 M	$ 3.94	-4.27 %	$ 55.4 M	USA
Rockwell Medical RMTI	11.6 M	$ 0.82	-5.27 %	$ 19.1 M	USA
Pacira BioSciences PCRX	368 M	$ 26.32	-0.72 %	$ 1.22 B	USA
Sundial Growers SNDL	1.03 M	$ 1.72	-0.87 %	$ 3.37 M	Canada
PetIQ PETQ	456 M	-	1.64 %	$ 400 M	USA
Jupiter Wellness JUPW	6.38 K	-	-	$ 33.6 M	USA
Veru VERU	6.71 M	$ 2.23	-7.25 %	$ 301 M	USA
Perrigo Company plc PRGO	4.28 B	$ 13.88	0.43 %	$ 1.91 B	USA
ProPhase Labs PRPH	7.94 M	$ 0.44	-14.65 %	$ 6.97 M	USA
cbdMD YCBD	2.49 M	$ 1.48	-12.2 %	$ 6.38 M	USA
Radius Health RDUS	200 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	111 M	-	-4.76 %	$ 65.3 M	USA
Relmada Therapeutics RLMD	2.66 M	$ 4.43	-1.77 %	$ 133 M	USA
OptiNose OPTN	130 M	-	-	$ 1.08 B	USA
Assertio Holdings ASRT	115 M	$ 9.62	-3.27 %	$ 683 M	USA
PLx Pharma PLXP	34 M	-	-27.8 %	$ 2.56 M	USA
Solid Biosciences SLDB	21.2 M	$ 5.73	-1.97 %	$ 234 M	USA
SCYNEXIS SCYX	53.4 M	$ 0.63	7.32 %	$ 30.1 M	USA
Tilray TLRY	570 M	$ 9.25	-3.62 %	$ 5.72 B	Canada
TherapeuticsMD TXMD	246 M	$ 1.71	-1.72 %	$ 17.9 M	USA